Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity

Journal of Hepatology

Volumn 54, Issue 1, 2011, Pages 153-159

  Simonen, Piia ^a,e   Kotronen, Anna ^a,b   Hallikainen, Maarit ^c,d   Sevastianova, Ksenia ^a,b   Makkonen, Janne ^a,b   Hakkarainen, Antti ^a   Lundbom, Nina ^a   Miettinen, Tatu A ^a   Gylling, Helena ^c,d   Yki Järvinen, Hannele ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e BIOMEDICUM HELSINKI   (Finland)

Author keywords

Cholestanol; Cholesterol absorption; Cholesterol synthesis; Lathosterol; Magnetic resonance spectroscopy; Non alcoholic fatty liver disease; Sitosterol

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; DESMOSTEROL; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOMEOSTASIS; HUMAN; LIPID ABSORPTION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL;

ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, LDL; FATTY LIVER; FEMALE; HUMANS; INSULIN; INTESTINAL ABSORPTION; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OBESITY; SITOSTEROLS; YOUNG ADULT;

EID: 78649632998     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.05.037     Document Type: Article

References (44)

1. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219
2. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Boparai, Y.C. Liu, and A.J. McCullough Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
3. A. Kotronen, J. Westerbacka, R. Bergholm, K.H. Pietiläinen, and H. Yki-Järvinen Liver fat in the metabolic syndrome J Clin Endocrinol Metab 92 2007 3490 3497
4. A. Seppälä-Lindroos, S. Vehkavaara, A.M. Häkkinen, T. Goto, J. Westerbacka, and A. Sovijärvi Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men J Clin Endocrinol Metab 87 2002 3023 3028
5. L. Ryysy, A.M. Häkkinen, T. Goto, S. Vehkavaara, J. Westerbacka, and J. Halavaara Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients Diabetes 49 2000 749 758
6. M. Hamaguchi, T. Kojima, N. Takeda, C. Nagata, J. Takeda, and H. Sarui Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease World J Gastroenterol 13 2007 1579 1584
7. H. Yki-Järvinen Fat in the liver and insulin resistance Ann Med 37 2005 347 356
8. C.D. Byrne, R. Olufadi, K.D. Bruce, F.R. Cagampang, and M.H. Ahmed Metabolic disturbances in non-alcoholic fatty liver disease Clin Sci 116 2009 539 564
9. A. Reunanen, T.A. Miettinen, and E.A. Nikkilä Quantitative lipid analysis of human liver needle biopsy specimens Acta Med Scand 186 1969 149 150
10. T.A. Miettinen Cholesterol production in obesity Circulation 44 1971 842 847
11. T.A. Miettinen, and H. Gylling Cholesterol absorption efficiency and sterol metabolism in obesity Atherosclerosis 153 2000 241 248
12. H. Gylling, M. Hallikainen, M. Kolehmainen, L. Toppinen, J. Pihlajamäki, and H. Mykkänen Cholesterol synthesis prevails over absorption in metabolic syndrome Transl Res 149 2007 310 316 (Pubitemid 46818162)
13. L.J. Bennion, and S.M. Grundy Effects of diabetes mellitus on cholesterol metabolism in man N Eng J Med 296 1977 1365 1371
14. H. Gylling, and T.A. Miettinen Cholesterol absorption, synthesis, and LDL metabolism in NIDDM Diabetes Care 20 1997 90 95
15. P.P. Simonen, H.K. Gylling, and T.A. Miettinen Diabetes contributes to cholesterol metabolism regardless of obesity Diabetes Care 25 2002 1511 1515
16. P.P. Simonen, H. Gylling, and T.A. Miettinen Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics Obes Res 10 2002 328 335
17. T.A. Miettinen, R.S. Tilvis, and Y.A. Kesäniemi Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men Metabolism 38 1989 136 140
18. T.A. Miettinen, R.S. Tilvis, and Y.A. Kesäniemi Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population Am J Epidemiol 131 1990 20 31
19. P. Simonen, H. Gylling, and T.A. Miettinen The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes Atherosclerosis 197 2008 883 888
20. L.S. Szczepaniak, P. Nurenberg, D. Leonard, J.D. Browning, J.S. Reingold, and S. Grundy Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population Am J Physiol Endocrinol Metab 288 2005 E462 E468
21. A.H. Kadish, R.L. Little, and J.C. Sternberg A new and rapid method for determination of glucose by measurement of the rate of oxygen consumption Clin Chem 14 1968 116 131
22. H. Kuzuya, P.M. Blix, D.L. Horwitz, D.F. Steiner, and A.H. Rubenstein Determination of free and total insulin and C-peptide in insulin-treated diabetics Diabetes 26 1977 22 29
23. T.A. Miettinen Cholesterol metabolism during ketoconazole treatment in man J Lipid Res 29 1988 43 51
24. van der Bogaart A, van Hecke A, van Huffel P, Graveron-Demilly S, van Ormondt D. MRUI: a graphical user interface for accurate routine MRS data analysis. Proceedings of the ESMRMB 13th Annual Meeting 1996; p. 318.
25. L. Vanhamme, A. van den Boogaart, and S. Van Huffel Improved method for accurate and efficient quantification of MRS data with use of prior knowledge J Magn Reson 129 1997 35 43
26. A. Kotronen, M. Peltonen, A. Hakkarainen, K. Sevastianova, R. Bergholm, and L.M. Johansson Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors Gastroenterology 137 2009 865 872
27. E. Sehayek, and J.L. Breslow Plasma plant sterol levels: another coronary heart disease risk factor? Arterioscler Thromb Vasc Biol 25 2005 5 6
28. E. Ikonen Cellular cholesterol trafficking and compartmentalization Nat Rev Mol Cell Biol 9 2008 125 138
29. J. Pihlajamäki, H. Gylling, T.A. Miettinen, and M. Laakso Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men J Lipid Res 45 2004 507 517
30. P. Simonen, H. Gylling, A.N. Howard, and T.A. Miettinen Introducing a new component of the metabolic syndrome: low cholesterol absorption Am J Clin Nutr 72 2000 82 88
31. M.S. Brown, and J.L. Goldstein The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 89 1997 331 340
32. J.D. Horton, J.L. Goldstein, and M.S. Brown SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J Clin Invest 109 2002 1125 1131
33. J.J. Repa, G. Liang, J. Ou, Y. Bashmakov, J.M. Lobaccaro, and I. Shimomura Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta Genes Dev 14 2000 2819 2830
34. F. Caballero, A. Fernandez, A.M. De Lacy, J.C. Fernandez-Checa, J. Caballeria, and C. Garcia-Ruiz Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH J Hepatol 50 2009 789 796
35. P. Puri, R.A. Baillie, M.M. Wiest, F. Mirshahi, J. Choudhury, and O. Cheung A lipidomic analysis of nonalcoholic fatty liver disease Hepatology 46 2007 1081 1090
36. S.W. Altmann, H.R. Davis Jr., L.J. Zhu, X. Yao, L.M. Hoos, and G. Tetzloff Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption Science 303 2004 1201 1204
37. K.E. Berge, H. Tian, G.A. Graf, L. Yu, N.V. Grishin, and J. Schultz Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters Science 290 2000 1771 1775
38. M.H. Lee, K. Lu, S. Hazard, H. Yu, S. Shulenin, and H. Hidaka Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption Nat Genet 27 2001 79 83
39. L. Yu, R.E. Hammer, J. Li-Hawkins, K. von Bergmann, D. Lütjohann, and J.C. Cohen Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion PNAS 99 2002 16237 16242
40. L. Yu, J. Li-Hawkins, R.E. Hammer, K.E. Berge, J.D. Horton, and J.C. Cohen Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol J Clin Invest 110 2002 671 680
41. K.E. Berge, K. von Bergmann, D. Lütjohann, R. Guerra, S.M. Grundy, and H.H. Hobbs Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8 J Lipid Res 43 2002 486 494
42. H. Gylling, M. Hallikainen, J. Pihlajamäki, J. gren, M. Laakso, and R.A. Rajaratnam Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity J Lipid Res 45 2004 1660 1665
43. J.C. Cohen, A. Pertsemlidis, S. Fahmi, S. Esmail, G.L. Vega, and S.M. Grundy Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels Proc Natl Acad Sci USA 103 2006 1810 1815
44. S.B. Biddinger, J.T. Haas, B.B. Yu, O. Bezy, E. Jing, and W. Zhang Hepatic insulin resistance directly promotes formation of cholesterol gallstones Nat Med 14 2008 778 782